What to do about the leaky gut

M Camilleri, A Vella - Gut, 2022 - gut.bmj.com
The potential role of 'leaky gut'or reduced barrier function with increased intestinal
permeability has been considered an important factor in intestinal and extraintestinal …

[HTML][HTML] COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?

J Troisi, G Venutolo, MP Tanya, MD Carri… - World journal of …, 2021 - ncbi.nlm.nih.gov
Gastrointestinal (GI) symptoms have been described in a conspicuous percentage of
coronavirus disease 2019 (COVID-19) patients. This clinical evidence is supported by the …

Present and future therapeutic approaches to barrier dysfunction

M Fortea, M Albert-Bayo, M Abril-Gil… - Frontiers in …, 2021 - frontiersin.org
There is converging and increasing evidence, but also uncertainty, for the role of abnormal
intestinal epithelial barrier function in the origin and development of a growing number of …

Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives

B Fevang - Expert Review of Clinical Immunology, 2023 - Taylor & Francis
Introduction Patients with common variable immunodeficiency (CVID) have a high frequency
of inflammatory complications like autoimmune cytopenias, interstitial lung disease and …

Peptide derivatives of the zonulin inhibitor larazotide (AT1001) as potential anti SARS-CoV-2: molecular modelling, synthesis and bioactivity evaluation

S Di Micco, S Musella, M Sala, MC Scala… - International journal of …, 2021 - mdpi.com
A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
been identified as the pathogen responsible for the outbreak of a severe, rapidly developing …

Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2

S Di Micco, R Rahimova, M Sala, MC Scala… - European Journal of …, 2022 - Elsevier
Although vaccines are greatly mitigating the worldwide pandemic diffusion of SARS-Cov-2,
therapeutics should provide many distinct advantages as complementary approach to …

Novel drug therapeutics in celiac disease: a pipeline review

S Varma, S Krishnareddy - Drugs, 2022 - Springer
Celiac disease (CeD) is a chronic, autoimmune systemic disorder triggered by the ingestion
of gluten, a protein found in foods such as wheat, rye, and barley. The only effective …

The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever

GJ Silverman, DF Azzouz, N Gisch… - Nature Reviews …, 2024 - nature.com
For more than a century, certain bacterial infections that can breach the skin and mucosal
barriers have been implicated as common triggers of autoimmune syndromes, especially …

3-chymotrypsin-like protease in SARS-CoV-2

K Al Adem, JC Ferreira, AJ Villanueva, S Fadl… - Bioscience …, 2024 - portlandpress.com
Coronaviruses constitute a significant threat to the human population. Severe acute
respiratory syndrome coronavirus-2, SARS-CoV-2, is a highly pathogenic human …

Micronutrient improvement of epithelial barrier function in various disease states: a case for adjuvant therapy

KM DiGuilio, E Rybakovsky, R Abdavies… - International Journal of …, 2022 - mdpi.com
The published literature makes a very strong case that a wide range of disease morbidity
associates with and may in part be due to epithelial barrier leak. An equally large body of …